PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 30 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $36,000 | +500.0% | 364,520 | +2011.3% | 0.00% | – |
| Q2 2016 | $6,000 | -40.0% | 17,265 | -32.8% | 0.00% | – |
| Q1 2016 | $10,000 | -71.4% | 25,684 | -71.5% | 0.00% | -100.0% |
| Q4 2015 | $35,000 | -34.0% | 90,099 | -2.7% | 0.00% | 0.0% |
| Q3 2015 | $53,000 | +120.8% | 92,586 | +112.1% | 0.00% | – |
| Q2 2015 | $24,000 | -76.0% | 43,654 | -64.4% | 0.00% | -100.0% |
| Q1 2015 | $100,000 | -74.9% | 122,755 | -75.3% | 0.00% | -71.4% |
| Q4 2014 | $398,000 | +2742.9% | 497,116 | +3566.6% | 0.01% | – |
| Q3 2014 | $14,000 | -81.6% | 13,558 | -84.6% | 0.00% | -100.0% |
| Q2 2014 | $76,000 | – | 88,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,226,961 | $221,000 | 0.02% |
| HOME FEDERAL BANK OF TENNESSEE | 100,000 | $10,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 1,077,555 | $107,000 | 0.00% |
| Cutter & CO Brokerage, Inc. | 79,500 | $8,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 81,647 | $8,000 | 0.00% |
| WADE G W & INC | 80,000 | $8,000 | 0.00% |
| PRINCETON CAPITAL MANAGEMENT LLC | 10,000 | $1,000 | 0.00% |
| Virtu KCG Holdings LLC | 364,520 | $36,000 | 0.00% |
| UBS Group AG | 309,214 | $31,000 | 0.00% |
| CITIGROUP INC | 1,000 | $0 | 0.00% |